19 results
8-K
SYRS
Syros Pharmaceuticals Inc.
13 Oct 21
Departure of Directors or Certain Officers
4:01pm
of Principal Officers.
On October 12, 2021, we announced the hiring and appointment of Jason Haas as the Chief Financial Officer of Syros
8-K
EX-10.1
SYRS
Syros Pharmaceuticals Inc.
13 Oct 21
Departure of Directors or Certain Officers
4:01pm
) of this paragraph shall not apply to the recruitment or hiring or other engagement of any individual whose employment or other engagement with Syros has been
10-K
2016 FY
EX-10.13
SYRS
Syros Pharmaceuticals Inc.
20 Mar 17
Annual report
12:00am
of the Consultant’s services with the Company; provided, that this clause (ii) shall not apply to the recruitment or hiring or other engagement of any
8-K
EX-2.1
x9vxha
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
10-K
hyzyw08 rqynn9
20 Mar 17
Annual report
12:00am
S-4
iziv koxk5
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
424B3
j37g 5a8arysvp4qtuj
8 Aug 22
Prospectus supplement
5:47pm
- Prev
- 1
- Next